GlassScriptPhysician profile
Anthony Ray Surratt
NPI 1922623529
$1,988.05
in general payments reported to CMS, 2019-2025
8 companies · $578 in 2025
The $578 reported for 2025 was more than what 91% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.67 · 2022: $217 · 2023: $147 · 2024: $970 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Gift: $568 · Education: $268 · Entertainment: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.64 |
| Gift | $567.97 |
| Education | $268.21 |
| Entertainment | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,008.84 | 2021-2024 | Suresmile |
| Ultradent Products INC | $578.42 | 2025 | Opalescence |
| Centrix INC | $177.89 | 2022 | |
| Ivoclar Vivadent, INC. | $118.59 | 2023 | |
| Elevate Oral Care | $38.28 | 2021-2022 | |
| 3m Company | $28.82 | 2023 | Clinpro 5000, 3m Relyx, Scotchbond Universal Plus |
| Patterson Companies, INC. | $19.00 | 2021 | |
| Envista Holdings Corporation | $18.21 | 2024 | Maxcem Elite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Surratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.